Thrombo Check/Thrombophilia Panel III is an extensive diagnostic test designed to evaluate the risk factors associated with blood clot formation, known as thrombophilia. This comprehensive panel encompasses various crucial assessments, including Factor VIII, Protein C functional, Free Protein S antigen, Anti Thrombin III functional, Factor V Leiden mutation, Prothrombin gene mutation, MTHFR gene mutation, Lupus Anticoagulant - DRVVT, Homocysteine, Anticardiolipin IgG/IgM, and Beta2 glycoprotein IgG & IgM.
Profile NameThrombo Check / Thrombophilia Panel III
Sample TypeBlood
Preparations RequiredNothing specific
Report Time5 days
Understanding thrombophilia is imperative due to its potential to lead to life-threatening conditions such as stroke, heart attack, deep vein thrombosis (DVT), and pulmonary embolism (PE). Early detection and efficient management of thrombophilia significantly mitigate the risk of these severe complications.
For information regarding Thrombo Check Panel 3 test cost and price, as well as details about the thrombocheck panel test, thrombocheck profile, and insights into Thrombophlebitis, please consult with healthcare professionals or specialised sprint diagnostic centers. Taking proactive steps to assess and address thrombophilia can be pivotal in safeguarding against its potential adverse effects on health.
Home Sample Collection Process
1
Book your convenient slot
2
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
4
Download Reports
Note: Home Sample Collection is only for Pathology lab tests.
Frequently Asked Questions
The Thrombo Check/Thrombophilia Panel III evaluates proteins and gene mutations linked to blood clotting,
assisting in discovering any inherited or received conditions that might boost the threat of blood
clots.
No unique guidance is required. However, it is important to inform your health practitioner about
medicinal drugs, nutrients, or dietary supplements you are taking, as they may affect the check effects.
The take a look includes a trendy blood draw conducted by a healthcare professional in a scientific
place. The accumulated blood sample is then despatched to a laboratory for specific analysis.
Like any blood draw, there is a moderate danger of bruising, bleeding, contamination on the needle site,
or fainting in the course of the process. However, those dangers are usually minimal.
The test looks at effects to help healthcare companies decide if there may be a genetic or obtained
inclination to expand blood clots. If abnormalities are determined, additional exams or treatments may
be endorsed to manipulate the danger of blood clots.
